Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28.80 | 1 | 69.4% |
| Education | $12.70 | 1 | 30.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $28.80 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.80 | 1 | ABBVIE INC. ($28.80) |
| 2019 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 453 | 845 | $210,342 | $67,693 |
| 2022 | 6 | 470 | 917 | $163,455 | $64,943 |
| 2021 | 5 | 562 | 1,091 | $184,446 | $76,423 |
| 2020 | 6 | 501 | 1,118 | $190,750 | $81,255 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 327 | $90,432 | $30,112 | 33.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 185 | 205 | $67,936 | $20,154 | 29.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 248 | $45,786 | $15,259 | 33.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 28 | $2,552 | $988.25 | 38.7% |
| 99448 | Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | Facility | 2023 | 17 | 18 | $2,008 | $678.24 | 33.8% |
| 99447 | Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | Facility | 2023 | 16 | 19 | $1,628 | $501.12 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 303 | $57,570 | $24,163 | 42.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 178 | 210 | $56,280 | $21,373 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 114 | 274 | $37,812 | $15,060 | 39.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 34 | 73 | $5,256 | $2,081 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,612 | $1,144 | 31.7% |
| 99447 | Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | Facility | 2022 | 28 | 32 | $2,080 | $888.84 | 42.7% |
| 99447 | Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | Office | 2022 | 13 | 13 | $845.00 | $233.12 | 27.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 229 | 259 | $69,412 | $27,223 | 39.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 89 | 317 | $60,230 | $25,893 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 137 | 296 | $39,232 | $16,815 | 42.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 80 | 191 | $13,752 | $5,738 | 41.7% |
| 99447 | Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 11-20 minutes of medical consultative discussion and review | Office | 2021 | 27 | 28 | $1,820 | $753.76 | 41.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 195 | 241 | $64,588 | $26,096 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 83 | 299 | $56,810 | $25,131 | 44.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 140 | 385 | $50,050 | $22,301 | 44.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 54 | 159 | $11,448 | $5,054 | 44.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $4,134 | $1,470 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 20 | $3,720 | $1,203 | 32.3% |
About Dr. Phalgun Prativadi, M.D
Dr. Phalgun Prativadi, M.D is a Infectious Disease healthcare provider based in Monroeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598920985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phalgun Prativadi, M.D has received a total of $41.50 in payments from pharmaceutical and medical device companies, with $28.80 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($28.80).
As a Medicare-enrolled provider, Prativadi has provided services to 1,986 Medicare beneficiaries, totaling 3,971 services with total Medicare billing of $290,314. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Monroeville, PA
- Active Since 07/24/2008
- Last Updated 11/04/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1598920985
Products in Payments
- DALVANCE (Drug) $28.80
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.